MIM
PDSB icon

Monashee Investment Management’s PDS Biotechnology PDSB Stock Holding History

Monashee Investment Management’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-80,000
Closed -$1M – 343
2021
Q2 		$1M Buy
+80,000
New +$625K 0.12% 192

Other funds holding PDSB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return

Monashee Investment Management's PDSB Position: Q3 2021 in Review

Monashee Investment Management sold out of PDS Biotechnology (PDSB) in Q3 2021, closing a stake of 80,000 shares — an estimated $1M sold.

Monashee Investment Management first reported a position in PDSB in Q2 2021 and held it in 1 quarter. The position peaked at $1M in Q2 2021. 59 funds tracked by Wall St. Rank hold PDSB as of Q3 2021.

  • Monashee Investment Management reported no remaining PDS Biotechnology position as of Q3 2021 after selling out during the quarter.
  • Monashee Investment Management sold 80,000 PDS Biotechnology shares in Q3 2021, an estimated $1M.
  • Monashee Investment Management first reported a position in PDS Biotechnology in Q2 2021 and held it in 1 quarter.
  • Monashee Investment Management's PDS Biotechnology position peaked at $1M in Q2 2021.
  • 59 funds tracked by Wall St. Rank held PDS Biotechnology as of Q3 2021.

Based on Monashee Investment Management's 13F filing for Q3 2021, filed 9 Nov 2021.